that can be given by monthly subcutaneous injection in the EU. The green light means that anti-complement C5 antibody PiaSky (crovalimab) has now been cleared in the top four world pharma markets ...

PharmaJet ®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free technology, today announced their upcoming poster presentation on November 13, ...

Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Needle Free Injections Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" ...

The size of the increase suggests the results ... Vutrisiran, meanwhile, is administered by physician-administered subcutaneous injection once every three months and brought in sales of $558 ...

Doses of vaccine should not be reduced despite the size of the infant. There is some indication that very-low-birth-weight infants have a reduced immune response. The AAP reports that there are ...